Literature DB >> 6821643

Effects of methotrexate in vitro on epidermal cell proliferation.

J R Taylor, K M Halprin, V Levine, C Woodyard.   

Abstract

Epidermal cell migration activity and epidermal cell proliferation are clearly dissociable in explant culture. Epidermal cell migration requires a non-dialysable, 65,000 mol. wt factor which is destroyed at 100 degrees C but is stable at 80 degrees C for at least 30 min. In the presence of dialysed serum or heated (80 degrees C for 30 min) or DNA synthesis inhibitors (methotrexate or hydroxyurea), cells will migrate from the explant but will not proliferate. At least two factors are required for normal proliferation under these restricted conditions--an adequate supply of DNA precursers, i.e. nucleosides, and a heat liable (80 degrees C) non-dialysable serum component. Methotrexate in concentrations of 1.0 microgram/ml or greater added to cultures in normal fetal calf serum significantly inhibited mitoses; however, when added to serum dialysed to remove thymidine, mitotic inhibition occurred at a concentration of 0.1 microgram/ml of methotrexate and when added to dialysed serum and kept in dialysed serum, inhibition occurred with 0.01 microgram/ml of methotrexate. Methotrexate did not inhibit outgrowth. Hydroxyurea also inhibited mitoses but did not effect outgrowth.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6821643     DOI: 10.1111/j.1365-2133.1983.tb04578.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

1.  Growth and differentiation of human keratinocytes cultured on eye lens capsules.

Authors:  M C Lenoir; B A Bernard; J Ferracin; B Shroot; A J Vermorken
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

2.  Comparison of the enzymatic and explant methods for the culture of keratinocytes isolated from human foreskin.

Authors:  Mahmoud Orazizadeh; Mahmoud Hashemitabar; Somayeh Bahramzadeh; Freshteh Nejad Dehbashi; Sadegh Saremy
Journal:  Biomed Rep       Date:  2015-03-09

Review 3.  Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?

Authors:  B Lindelöf
Journal:  Drug Saf       Date:  1999-04       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.